Literature DB >> 10182888

The cost of inpatient endometriosis treatment: an analysis based on the Healthcare Cost and Utilization Project Nationwide Inpatient Sample.

S Z Zhao1, J M Wong, M B Davis, G E Gersh, K E Johnson.   

Abstract

OBJECTIVE: To determine the prevalence and cost of endometriosis-related hospitalizations based on the Nationwide Inpatient Sample (NIS) from the Healthcare Cost and Utilization Project (HCUP-3). STUDY
DESIGN: Retrospective analysis based on nationwide clinical practice data. PATIENTS AND METHODS: Data were obtained for 1991 and 1992 from the HCUP-NIS database, which was a 20% sample of all US hospital discharges. ICD-9 codes (236.0, 617.0 to 617.9) were used to identify females, aged 15 to 54, with endometriosis as a diagnosis. The distribution of endometriosis admissions by admission type, length of stay (LOS), mean total charge, specific types of endometriosis, principal procedures, and other diagnosed diseases was described.
RESULTS: In 1991 and 1992, 37,273 (22.6/1000) and 38,834 (23.7/1000) hospital admissions, respectively, were for endometriosis (as any diagnosis). The average LOS and total hospital charges for endometriosis as the primary diagnosis were 3.8 days and $6,597 for 1991, and 3.5 days and $7,450 for 1992. Most endometriosis admissions occurred in females aged 35 to 49. About 87% of the endometriosis hospitalizations were routine admissions. The most common diagnosis was endometriosis of the uterus (51%); the most common procedure was a total abdominal hysterectomy (55%-60%). Older and African-American patients had the longest LOS and the highest total charges. The estimated total hospitalization costs, as represented by hospital charges, for women with endometriosis as the primary diagnosis in the United States were $504 million for 1991 and $579 million for 1992.
CONCLUSION: Endometriosis-related hospitalization is a major burden on healthcare systems.

Entities:  

Mesh:

Year:  1998        PMID: 10182888

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  9 in total

1.  Secondary data bases and their use in outcomes research: a review of the area resource file and the Healthcare Cost and Utilization Project.

Authors:  A E Best
Journal:  J Med Syst       Date:  1999-06       Impact factor: 4.460

2.  Patients' report on how endometriosis affects health, work, and daily life.

Authors:  Jessica Fourquet; Xin Gao; Diego Zavala; Juan C Orengo; Sonia Abac; Abigail Ruiz; Joaquín Laboy; Idhaliz Flores
Journal:  Fertil Steril       Date:  2010-05-01       Impact factor: 7.329

3.  Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis.

Authors:  Christian M Becker; Paul Beaudry; Tae Funakoshi; Ofra Benny; Alexander Zaslavsky; David Zurakowski; Judah Folkman; Robert J D'Amato; Sandra Ryeom
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

4.  Noninvasive bladder testing of adolescent females to assess visceral hypersensitivity.

Authors:  Frank F Tu; Kevin M Hellman; Genevieve E Roth; Katlyn E Dillane; Lynn S Walker
Journal:  Pain       Date:  2022-01-01       Impact factor: 7.926

Review 5.  Revisiting the impact of race/ethnicity in endometriosis.

Authors:  Olga Bougie; Ikunna Nwosu; Chelsie Warshafsky
Journal:  Reprod Fertil       Date:  2022-03-17

6.  Differences in Clinical Management and Outcomes of American Indian and White Women Diagnosed With Endometriosis.

Authors:  Alessandra Spagnolia; James R Beal; Abe E Sahmoun
Journal:  J Family Reprod Health       Date:  2020-06

Review 7.  Variation among human populations in endometriosis and PCOS A test of the inverse comorbidity model.

Authors:  Bernard Crespi
Journal:  Evol Med Public Health       Date:  2021-09-17

8.  Endometriosis in an indigenous African women population.

Authors:  Samuel Ohayi; Nnaemeka Onyishi; Sunday Mbah
Journal:  Afr Health Sci       Date:  2022-03       Impact factor: 1.108

9.  Trends in Outcomes and Hospitalization Charges among Mechanically Ventilated Patients with Myasthenia Gravis in the United States.

Authors:  Nizar Souayah; Abu Nasar; M Fareed K Suri; Jawad F Kirmani; Mustapha A Ezzeddine; Adnan I Qureshi
Journal:  Int J Biomed Sci       Date:  2009-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.